Ignite Creation Date:
2025-12-24 @ 9:15 PM
Ignite Modification Date:
2026-01-04 @ 9:01 PM
Study NCT ID:
NCT03343704
Status:
COMPLETED
Last Update Posted:
2025-02-25
First Post:
2017-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
This Study Looks at the Effects of Idarucizumab in Patients Who Take Dabigatran and Need Emergency Surgery or Are Bleeding
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-26
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-02
Completion Date Type:
ACTUAL
First Submit Date:
2017-11-13
First Submit QC Date:
None
Study First Post Date:
2017-11-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-06-29
Results First Submit QC Date:
None
Results First Post Date:
2021-08-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-10
Last Update Post Date:
2025-02-25
Last Update Post Date Type:
ACTUAL